Skip Main Navigation
Page Content

Save This Event

Event Saved

Artificial Intelligence for Drug Discovery

JLABS @ Toronto

Tuesday, December 12, 2017 from 4:00 PM to 8:00 PM (EST)

Artificial Intelligence for Drug Discovery

Ticket Information

Ticket Type Sales End Price * Fee Quantity
General Public   more info Dec 11, 2017 CA$25.00 CA$2.11
Media/Press   more info Dec 5, 2017 Free CA$0.00
Volunteer   more info Dec 5, 2017 Free CA$0.00
* Prices include GST/HST

Share Artificial Intelligence for Drug Discovery

Event Details


Artificial intelligence (AI) poses unlimited opportunity for us to make a transformative impact on patients. Whether it be through new drug combinations, improved medical diagnostics, better accuracy in personalized medicine, or many other benefits - AI could save scientists valuable research time and bring new treatments to patients more quickly.

For this reason, Johnson & Johnson Innovation and Janssen Research & Development launched the Artificial Intelligence for Drug Discovery QuickFire Challenge. Johnson & Johnson Innovation will award up to $100,000 in grants, one year of JLABS residency & mentorship to the individuals or teams who submit the best ideas, technologies, or solutions that are using artificial intelligence to advance healthcare.

On December 12th, join us at JLABS @ Toronto as we hear from the finalists of this challenge and choose the winner(s) with the help of a judging panel & the attendees.

During deliberations attendees will hear from an esteemed panel of experts in the artificial intelligence/machine learning field, with speakers from Janssen R&D, Real Ventures, Vector Institute, University of Toronto & Cyclica Inc.

APPLICATIONS ARE STILL OPEN: https://jlabs.tv/aichallenge .
Deadline: October 27th at 11:59PM EST

Agenda
4:00pm | Registration Opens & Networking
4:15pm | Opening Remarks
4:30pm | Presentations from Finalists
5:30pm | Bio Break
5:45pm | Panel Discussion
6:45pm | Q&A
7:00pm | Networking
7:30pm | Announcement of Winners
8:00pm | Program Close

Speakers
JS Cournoyer | General Partner, Real Ventures read bio»
Anna Goldenberg | Scientist, The Hospital for Sick Children; Assistant Professor, University of Toronto Department of Computer Science read bio»
Naheed Kurji | President & CEO, Cyclica Inc. read bio»
Andrea Proctor | Director of Health Care Engagement, Vector Institute read bio»
Guna Rajagopal | Global Head, Computational Sciences, Janssen Research & Development read bio»

Fees
$25 | General Public

Location
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Speaker Biography:
JS Cournoyer | General Partner, Real Ventures
JS is an entrepreneur at heart. When he is not taking care of his five children, he chooses to dedicate his life helping passionate entrepreneurs trying to change the world realize their vision and succeed in life and in business. JS likes to work with entrepreneurs who use A.I and blockchain technologies to improve human creativity, communication and happiness or to transform the pillars of our society (health, education, food, energy, government, finance, work, transportation).


Anna Goldenberg | Scientist, The Hospital for Sick Children; Assistant Professor, University of Toronto Department of Computer Science
Dr Goldenberg is a Scientist in Genetics and Genome Biology program at the SickKids Research Institute and an Assistant Professor in the Department of Computer Science at the University of Toronto. She is also a fellow of the Canadian Institute for Advanced Research and a member of Vector Institute. Dr Goldenberg’s lab develops machine learning approaches that efficiently combine many types of patient measurements to refine diagnosis, improve prognosis and personalise drug response prediction in the context of complex human diseases. Dr Goldenberg was recently awarded an Early Researcher Award from the Ministry of Research and Innovation.


Naheed Kurji | President & CEO, Cyclica Inc.
Naheed is President and CEO of Cyclica, where he leads the team in delivering the next step in cloud-based drug discovery. Naheed focuses on corporate and business growth strategies to ensure the company is set up for success. Naheed received his MBA from the University of Toronto, Rotman School of Management. Prior to joining Cyclica, Naheed worked as an Associate Director at Bank of Montreal in Calgary where he was integral in multiple cross-border sponsor coverage deals.


Andrea Proctor | Director of Health Care Engagement, Vector Institute
Bio coming soon!


Guna Rajagopal | Global Head, Computational Sciences, Janssen Research & Development
Guna’s team is mandated to provide “big data analytics”, high performance computing and genetics/genomics expertise to address and support the evolving need of researchers to identify and validate safe and effective large and small molecule drugs. He is a member of the Discovery Sciences Board, Chair of the R&D Informatics Committee and the J&J Real World Evidence (RWE) Senior Leadership team. Before joining Janssen, Guna was at the Rutgers Cancer Institute of New Jersey (CINJ), a NCI-designated Comprehensive Cancer Center, as Executive Director (Bioinformatics) and an Adjunct Professor of Radiation Oncology at the Robert Wood Johnson Medical School. In addition, with funding from the state of New Jersey and the Robert Wood Johnson Foundation, his team deployed inter-operable EMR’s that increases operational efficiency and improved treatment outcomes. Guna received his PhD in theoretical physics from the Georgia Institute of Technology and his undergraduate and MSc (in Particle Physics) from the University of Malaya.

Have questions about Artificial Intelligence for Drug Discovery? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where


JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1
Canada

Tuesday, December 12, 2017 from 4:00 PM to 8:00 PM (EST)


  Add to my calendar

Organizer

JLABS @ Toronto

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer
Artificial Intelligence for Drug Discovery
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.